Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 09-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||
| Net Income | -9,000 | N/A | N/A |
| Depreciation Amortization | 30 | N/A | N/A |
| Other Working Capital | -140 | N/A | N/A |
| Other Operating Activity | 6,310 | 0 | 0 |
| Operating Cash Flow | $-2,800 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -2 | N/A | N/A |
| Net Acquisitions | -140 | N/A | N/A |
| Other Investing Activity | -18 | 0 | 0 |
| Investing Cash Flow | $-160 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 6,960 | 0 | 0 |
| Financing Cash Flow | $6,960 | $N/A | $N/A |
| Beginning Cash Position | 120 | N/A | N/A |
| End Cash Position | 4,120 | N/A | N/A |
| Net Cash Flow | $3,990 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -2,800 | N/A | N/A |
| Free Cash Flow | -2,800 | 0 | 0 |